Injected Drug Approved for Melanoma Skin Cancer

WEDNESDAY, Oct. 28, 2015 — Imlygic (talimogene laherparepvec) has been approved by the U.S. Food and Drug Administration to treat melanoma of the skin and lymph nodes.
Melanoma is the leading cause of death from skin cancer, affecting some 74,000…
Source: Topamax